IRIS
SPORTIELLO, Liberata
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.267
NA - Nord America 2.798
AS - Asia 2.294
SA - Sud America 377
Continente sconosciuto - Info sul continente non disponibili 153
AF - Africa 37
OC - Oceania 3
AN - Antartide 1
Totale 10.930
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.638
US - Stati Uniti d'America 2.746
SG - Singapore 749
CN - Cina 558
IE - Irlanda 467
IT - Italia 412
VN - Vietnam 347
BR - Brasile 305
HK - Hong Kong 245
GB - Regno Unito 187
DE - Germania 160
UA - Ucraina 131
KR - Corea 99
JP - Giappone 83
IN - India 78
GR - Grecia 47
FI - Finlandia 46
TR - Turchia 38
AR - Argentina 35
FR - Francia 34
SE - Svezia 27
CA - Canada 26
NL - Olanda 23
ID - Indonesia 18
EC - Ecuador 17
ZA - Sudafrica 17
BD - Bangladesh 16
AT - Austria 15
BE - Belgio 13
CZ - Repubblica Ceca 12
ES - Italia 12
IQ - Iraq 12
MX - Messico 12
PL - Polonia 10
IR - Iran 8
PK - Pakistan 8
CH - Svizzera 7
MA - Marocco 7
IL - Israele 6
CL - Cile 5
DK - Danimarca 5
PY - Paraguay 5
EG - Egitto 4
JM - Giamaica 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
HR - Croazia 3
KE - Kenya 3
LT - Lituania 3
NP - Nepal 3
PE - Perù 3
RS - Serbia 3
UZ - Uzbekistan 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
PH - Filippine 2
TN - Tunisia 2
AQ - Antartide 1
AU - Australia 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
KH - Cambogia 1
KI - Kiribati 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 10.778
Salva come PNG Salva come JPEG
Città #
Moscow 1.326
San Jose 483
Dublin 463
Singapore 359
Santa Clara 294
Hong Kong 243
Jacksonville 207
Chandler 176
Ashburn 156
Beijing 98
Ho Chi Minh City 98
Seoul 96
Hefei 78
Ann Arbor 68
Dong Ket 66
Hanoi 63
Aversa 57
Princeton 54
Roxbury 48
Medford 46
Bremen 45
Dallas 39
Woodbridge 35
Bengaluru 34
Orem 34
The Dalles 32
Los Angeles 31
New York 31
Naples 29
Caserta 28
Wilmington 28
São Paulo 27
Düsseldorf 26
Atlanta 24
Memphis 22
Milan 22
Mountain View 21
Nanjing 21
Da Nang 19
Des Moines 17
Genoa 17
Munich 16
Rome 16
Boardman 15
Dearborn 15
Amsterdam 14
Brussels 13
Cambridge 13
Chennai 13
London 13
Nuremberg 13
Kunming 12
San Francisco 12
Jinan 11
Toronto 11
Falkenstein 10
Frankfurt am Main 10
Haiphong 10
Helsinki 10
Johannesburg 10
Manchester 10
Napoli 10
Biên Hòa 9
Jakarta 9
Phủ Lý 9
Auburn Hills 8
Hanover 8
Messina 8
Mexico City 8
Pomigliano d'Arco 8
Salerno 8
Brasília 7
Brno 7
Brooklyn 7
Chengdu 7
Curitiba 7
Guangzhou 7
Mumbai 7
Rio de Janeiro 7
San Mateo 7
Shenyang 7
Stockholm 7
Vienna 7
Warsaw 7
Boston 6
Changsha 6
Chicago 6
Guarulhos 6
Hillsboro 6
Houston 6
Hải Dương 6
Norwalk 6
Asunción 5
Belo Horizonte 5
Cagliari 5
Can Tho 5
Columbus 5
Guayaquil 5
Hebei 5
Nanchang 5
Totale 5.572
Salva come PNG Salva come JPEG
Nome #
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 351
Adverse drug reactions and gender differences: What changes in drug safety? 227
Neutral endopeptidase (neprilysin) 211
Bisphosphonate-related osteonecrosis of the jaw: an italian post-marketing surveillance analysis 195
Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy 189
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 187
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 182
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 180
Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study 179
Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: A population-based study. 168
Complete resistance after maximal dose of rocuronium 168
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 168
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials 161
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: An observational study in real-life settings 159
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 158
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 158
Medication adherence and the use of new pharmaceutical formulations: The case of levothyroxine 157
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 155
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 155
Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve 153
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 151
Pattern of statin use in southern Italian primary care: Can prescription databases be used for monitoring long-term adherence to the treatment? 151
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis 148
Did the new Italian law on mandatory vaccines affect adverse event Following immunization's reporting? A pharmacovigilance study in Southern Italy 147
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 145
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 144
Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system 143
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 141
Current pharmacological treatments for COVID-19: What's next? 139
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study 138
Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management 138
Did the COVID-19 Pandemic Affect Contrast Media-Induced Adverse Drug Reaction’s Reporting? A Pharmacovigilance Study in Southern Italy 138
Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database 137
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 137
Disclosing negative trial results – procedure 135
Persistence in therapy with risperidone and aripiprazole in pediatric outpatients: A 2-year naturalistic comparison 134
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) 134
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary 133
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy 133
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review 128
Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study. 126
Hospital consumption of antibiotics at the Policlinico Hospital of the Second University of Naples: results of retrospective data collection 126
Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switch 126
Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand? 122
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data 122
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database 121
Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study 121
Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review 118
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination 117
Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case–control study in Italy 115
Rational use of antibiotics for the management of children's respiratory tract infections in the ambulatory setting: An evidence-based consensus by the Italian Society of Preventive and Social Pediatrics 114
DPP-4 inhibitors: Pharmacological differences and their clinical implications 113
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 113
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 112
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin. 110
Drugs approved for the treatment of multiple sclerosis: review of their safety profile 109
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL 108
Therapeutic strategies to fight COVID-19: Which is the status artis? 108
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 107
Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021) 106
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 106
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 106
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 106
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 105
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region 104
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments 104
Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series 103
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy 103
Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF) 101
Notification of undesirable effects of cosmetics and toiletries 99
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 99
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 99
MicroRNA Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study 98
Should we abandon statins in the prevention of bone fractures? 97
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 94
Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 monoclonal antibodies: a systematic review and meta-analysis of observational studies. 94
Immune checkpoint inhibitors and metabolic events: results from a European safety analysis. 88
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 81
The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice 80
It is the time to change the paradigms of pregnant and breastfeeding women in clinical research! 77
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs 77
Oropharyngeal adverse drug reactions: knowledge, attitudes, and practice (KAP) among Italian healthcare professionals and students 67
Sex and gender differences and pharmacovigilance: a knot still to be untied 65
Oro-Dental Pharmacovigilance in the Digital Age: Promoting Knowledge, Awareness, and Practice in Italy through a Smart Combined System—A Conference at the 30th National Congress of the Italian College of University Professors of Dental Disciplines 8
Totale 10.930
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.360
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.360
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022329 0 8 2 3 123 10 12 9 15 16 22 109
2022/2023872 91 21 12 58 95 58 6 48 423 6 35 19
2023/2024424 26 10 30 23 122 27 12 48 21 16 29 60
2024/20251.307 10 31 28 41 180 193 194 117 195 100 114 104
2025/20266.376 254 320 311 299 510 3.368 245 495 201 160 153 60
2026/2027364 169 195 0 0 0 0 0 0 0 0 0 0
Totale 10.930